Chapter 11 QUALITY IMPROVEMENT (QI)
282 l CHAPTER 11 l QUALITY IMPROVEMENT Chapter 11 QUALITY IMPROVEMENT (QI) 11.1 INTRODUCTION TO QUALITY IMPROVEMENT The quality of care delivered in your health centre is determined by many factors, including how its services are organized, leadership, monitoring systems, adequate infrastructure and available resources, both human and material.
Download Chapter 11 QUALITY IMPROVEMENT (QI)
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Measure Supplier Performance - Value Chain Group
valuechaingroup.comPerformance by Sherry Gordon 20 I AUGUST 2005 I www.asq.org very organization knows it should be assessing supplier performance. Most are deploying some sort of supplier perfor-mance measurement, whether it is a couple of rudi-mentary key performance indicators (KPIs) or more sophisticated data gathering and on-site assessment programs. But few ...
Quality Assurance and Performance Improvement Plan ...
www.hqi.solutionsEffective performance improvement efforts will focus on the development, maintenance and periodic improvement of systems that influence organizational outcomes. Systems will be designed and modified to achieve reliable, efficient outcomes. Objectives of the QAPI plan: a)Improve the quality of care thereby enhancing the quality of life for residents
Ongoing Professional Practice Evaluation (OPPE)
stanfordhealthcare.orgthorough evaluation of practitioner performance. The report will encompass hospital-wide indicators and specialty specific indicators. 3. At the time of reappointment, the Service Chief will review the most current 24 months of OPPE and FPPE data and document the interpretation and any improvement activities for each practitioner.
INSTRUCTIONS: Applying the AHRQ Quality Indicators to ...
www.ahrq.govIndicators (PSIs), Pediatric Indicators (PDIs), and Prevention Quality Indicators (PQIs). This toolkit addresses the IQIs and the PSIs, which apply to the inpatient setting. Refer to the IQI and PSI Fact Sheets (Tools A.1) in this toolkit for summary descriptions of these two sets of indicators. The AHRQ QIs are available for public use at no ...
Investment and Impact Fund 2020/21: guidance
www.england.nhs.uk3 | Investment and impact fund 2020/21: guidance 2. Structure of the IIF 2.1. This section introduces the key elements of the IIF in 2020/21: • domains, areas and indicators • indicator structure, performance and personalised care adjustments • achievement points • achievement payments, prevalence adjustment and list size adjustment • total achievement payments and …
www.meridium.com Enterprise APM Software
www.ge.comchallenges, and applying these advanced algorithms and innovative long text data mining and analysis, Cognitive Analytics can aggregate all of the data being collected and provide a full view of asset health and performance. APM Strategy Improve the plan At the heart of the Meridium Enterprise APM landscape
New York State Department of Health - Wadsworth Center
www.wadsworth.orgLaboratories located in New York State, and laboratories conducting clinical or forensic testing on specimens originating in New York State regardless of location, must hold a New York State Department of Health clinical laboratory permit pursuant to Article 5, Title V,